In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Fujifilm Promises A Shake-Up Of Regenerative Medicines Market

Executive Summary

Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.


Related Content

Deal Watch: Merck Digging Into Epigenetics With Proteros Partnership
Cellvation Tackling Traumatic Brain Injuries With Stem Cell Therapy
Cynata Sets Stage For Global Fujifilm Cell Therapy Deal
Fujifilm, CDI Agree $307m Acquisition
Kalon Stake Gives Fujifilm Ebola Vaccine Capacity


Related Companies

Related Deals